ASHLEIGH WESTFALL: Open Payments
NPI 1326387168 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$576 in 6 payments from 5 companies in 2025. Trend: 2023 $1,468 · 2024 $1,116 · 2025 $576
Food & beverage: $534Education: $43
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 1 | $180 |
| Corcept Therapeutics | 1 | $135 |
| Tandem Diabetes Care, Inc. | 2 | $115 |
| Novo Nordisk Inc | 1 | $103 |
| Mannkind Corporation | 1 | $43 |
Products named: FREESTYLE LIBRE 3, Korlym, t:slim X2 Insulin Pump with Control-IQ, Ozempic, AFREZZA.
Industry payments across TX — which companies pay providers there.
